Ascendis Pharma A/SASNDNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P7
Near historical low
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -7.65% |
| 2024 | -25.75% |
| 2023 | 8.91% |
| 2022 | 28.31% |
| 2021 | 13.40% |
| 2020 | 36.16% |
| 2019 | 36.60% |
| 2018 | 40.86% |
| 2017 | 50.84% |
| 2016 | 62.90% |